Why Gilead Sciences, Inc. (GILD) stock moved
Gilead Sciences, Inc. (GILD) shares fell 2.2% to $130.28 as of July 22, 2026, a modest decline from the prior close of $133.21. BestStocks flagged the session as a major change for GILD. No single company-specific catalyst was confirmed, so the move reads as a company-specific move. Below, we break down what changed for GILD, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
GILD fell 2.2% to $130.28
GILD fell 2.2% in its latest session, moving from $133.21 to $130.28.
What it means for Gilead Sciences, Inc. investors
For Gilead Sciences, Inc. investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: Positive price momentum; Positive price momentum. Weighing against that: Negative session, down 2.2%; Gilead Sciences, Inc. (GILD) moved -3.72% from $134.84 to $129.83 on 2026-07-10. Because the move outpaced peers, it looks driven by GILD-specific developments rather than a broad sector rotation. Wall Street's consensus price target sits at $159.28, implying +22.3% upside from $130.28. Over the past 90 days analysts logged 2 upgrades and 0 downgrades. BestStocks rates the overall signal quality weak (0/100). With earnings roughly 15 days out, the next report is the most likely near-term test of the move.
GILD price reaction
GILD last traded at $130.28, down $2.93 (-2.20%) from the previous close of $133.21. The session traded on 1.1× average volume (normal), so participation was unremarkable. Its healthcare peer group moved a median +1.1% over the same stretch, leaving GILD behind the group by 3.3 points. Over the past month the stock has ranged between $123.84 and $136.36, and it currently sits about 51% of the way up that band.
Bullish and bearish analyst opinions on Gilead Sciences, Inc. (GILD)
The consensus analyst price target on Gilead Sciences, Inc. (GILD) is $159.28, 22.3% above the recent $130.28. Over the past 90 days analysts logged 2 upgrades, 7 maintains, and 0 downgrades. Here is how the bullish and bearish cases on GILD line up.
The bullish case
- Wall Street's consensus price target of $159.28 implies +22.3% upside from $130.28.
- The Street's most bullish target is $180.00 (+38.2%).
- 2 analyst upgrades in the past 90 days, most recently HSBC to Buy (2026-07-06).
- Positive price momentum.
The bearish case
- The most bearish analyst target is $120.00 (-7.9%).
- Negative session, down 2.2%.
- Gilead Sciences, Inc. (GILD) moved -3.72% from $134.84 to $129.83 on 2026-07-10.
Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Jul 22, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for GILD
Frequently asked questions about GILD
Why did Gilead Sciences, Inc. (GILD) stock move?
GILD fell 2.2% to $130.28. No single company-specific catalyst was confirmed during the move window, and it looks like a company-specific move.
How much did GILD stock fall?
GILD lost 2.20% ($2.93) versus the prior close of $133.21, last trading at $130.28 on 1.1× average volume.
When is Gilead Sciences, Inc.'s next earnings date?
GILD's next earnings report is estimated for 2026-08-06 — about 15 days away.
What is the analyst price target for GILD?
The consensus analyst price target for GILD is $159.28, about 22.3% above the current $130.28. Over the past 90 days, analysts recorded 2 upgrades, 7 maintains, and 0 downgrades.
Is the GILD move company-specific or sector-wide?
BestStocks classifies it as a company-specific move: the peer group moved a median +1.1% against GILD's -2.2%. GILD ranks top 7 of 7 peers.
How BestStocks tracks GILD
This page is generated automatically by BestStocks' change-detection system after its price and volume cleared GILD-specific materiality thresholds, triggering an evidence check. It draws on 10 tracked change events for GILD, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of July 22, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.